It was found that CD5 antigen-like (Cd5l) administration attenuates sterile inflammation and that Cd5l deficiency courses severe neurological damage with higher mortality (Maehara et al., 2021). The gene discussed is CD5L; the disease is hyperinsulinemic hypoglycemia, familial, 4.